ARMP
Armata Pharmaceuticals, Inc.
Key Financials
Net Income
$-173799000
↓ 818.8%
Operating Income
$-36634000
↑ 13.7%
Total Assets
$76.9M
↓ 11.1%
EPS (Diluted)
$-4.80
↓ 439.3%
Shareholders' Equity
$-218596000.00
↓ 355.2%
Total Liabilities
$295.5M
↑ 119.8%
Cash & Equivalents
$8.7M
↓ 6.5%
Operating Cash Flow
$-25763000.00
↑ 31.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K/A | 6/24/2026 | View on SEC |
| 8-K | 6/23/2026 | View on SEC |
| 8-K | 6/16/2026 | View on SEC |
| SCHEDULE 13D/A | 5/13/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
| 8-K | 5/13/2026 | View on SEC |
| 8-K | 5/7/2026 | View on SEC |
| 4 | 4/28/2026 | View on SEC |
| 3 | 4/28/2026 | View on SEC |
| ARS | 4/27/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ARMP |
| Company Name | Armata Pharmaceuticals, Inc. |
| CIK | 921114 |
| Sector | Biological Products, (No Diagnostic Substances) |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | NYSE |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | WA |
| Phone | 310-665-2928 |